Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Drug Firm Valeant to Acquire Medicis
Sept. 5, 2012
Valeant Pharmaceuticals International has agreed to buy Medicis Pharmaceutical for $2.6 billion, the latest in a string of acquisitions that have transformed the Canadian drug maker into a multibillion-dollar global company.
The Wall Street Journal
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing